On Friday, Shares of Bristol-Myers Squibb Co (NYSE:BMY), gained 1.06% to $63.08.
Bristol-Myers Squibb Company and Otsuka America Pharmaceutical declared that the U.S. Food and Drug Administration (FDA) has approved an update to the Sprycel (dasatinib) product labeling. The labeling now comprises five-year efficacy and safety data in adult patients with newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase (CP) and seven-year data in CP Ph+ CML patients who are resistant1 or intolerant2 to preceding therapy, counting Gleevec 3 (imatinib mesylate).
“The five- and seven-year data now comprised of in the Sprycel U.S. label offer valuable insight into its long-term efficacy and safety profile in both first- and second-line patients,” said Neil Shah, MD, PhD, Associate Professor, Division of Hematology/Oncology, University of California, San Francisco. “CML requires ongoing treatment and assessment of treatment milestones in order to manage the disease properly. Given the chronic nature of CML, these long-term data are particularly important for patient care.”
Sprycel is associated with the following warnings and precautions: myelosuppression, bleeding-related events, fluid retention, cardiovascular events, pulmonary arterial hypertension, QT prolongation, severe dermatologic reactions, tumor lysis syndrome, and embryo-fetal toxicity. Please see detailed Important Safety Information below.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It provides chemically-synthesized drugs or small molecules, and biologics in various therapeutic areas, counting virology comprising human immunodeficiency virus infection (HIV); oncology; neuroscience; immunoscience; and cardiovascular.
Shares of Atlas Resource Partners, L.P. (NYSE:ARP), declined -5.69% to $3.98, during its last trading session.
Atlas Energy Group stated operating and financial results for the second quarter 2015.
- Atlas Energy’s Distributable Cash Flow, a non-GAAP measure, was about $5.0 million(1), or $0.19 per common unit, in the second quarter 2015.
- Atlas Resource Partners, L.P. (ARP), Atlas Energy’s E&P partner, paid monthly cash distributions totaling $0.325 per common limited partner unit for the second quarter 2015. The most recent ARP distribution for June 2015 will be paid on August 14, 2015 to holders of record as of August 7, 2015. Atlas Energy received $9.4 million in cash distributions in the second quarter 2015 from ownership in ARP.
- Atlas Growth Partners, L.P. (“AGP”), Atlas Energy’s private E&P development partner, recently accomplished its initial fundraising of about $233 million in investor capital for its operations, which are primarily focused in the Eagle Ford Shale.
- In July 2015, Arc Logistics Partners, LP (ARCX), a master limited partnership of which 16% of its general partner is owned by ATLS through the Company’s interest in Lightfoot Capital Partners, declared that it attained all of the limited liability company interests of UET Midstream, LLC, a crude oil and terminal business, from United Energy Trading, LLC and Hawkeye Midstream, LLC for a total adjusted purchase price of $76.6 million.
Atlas Resource Partners, L.P. operates as an independent developer and producer of natural gas, crude oil, and natural gas liquids in the United States. The company operates in three segments: Gas and Oil Production, Well Construction and Completion, and Other Partnership Administration.
Finally, Intercontinental Exchange Inc (NYSE:ICE), ended its last trade with 1.24% gain, and closed at $240.65.
Intercontinental Exchange declared that the Agency for the Cooperation of Energy Regulators (ACER) has approved ICE Trade Vault Europe Limited (ICE Trade Vault Europe) as a Registered Reporting Mechanism (RRM) to meet the reporting requirements of the European wholesale energy markets.
ICE Trade Vault Europe provides a trade repository solution across the commodities, credit, equity, FX and interest rate derivatives asset classes, following its successful launch in February 2014. The addition of the RRM Service further expands its commodity offering to the European wholesale energy markets, an important focus for ICE Trade Vault Europe.
David Peniket, Executive Director of ICE Trade Vault Europe, said “ICE Trade Vault Europe provides customers with a scalable and seamless trade repository solution which is now expanded following the approval by ACER to collect trade and order data for the European wholesale energy markets. We will continue to respond to our customers’ needs by offering an efficient trade reporting solution that supports their global regulatory and compliance needs.”
ICE Trade Vault Europe builds upon ICE’s widely recognized trading and clearing technology in addition to the confirmation and affirmation matching services, ICE eConfirm and ICE Link. ICE Trade Vault Europe was approved by the European Securities and Markets Authority (ESMA) as a trade repository during 2013 and has processed over one billion over-the-counter (OTC) and exchange-traded derivatives (ETD) reports. ICE Trade Vault Europe’s registration as a RRM is also subject to review by ESMA.
Intercontinental Exchange, Inc. operates a network of regulated exchanges and clearing houses for financial and commodity markets in the United States, the United Kingdom, Continental Europe, Israel, Canada, and Singapore.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.